Merck Czech Republic - Operating Cost Growth

Merck CR`s Operating Cost Growth reached 6.39 % in 2017. This is 10685 % more than in the previous year.

$1.99

Buy Operating Cost Growth data for Merck Czech Republic.

$19.99

Buy all data for Merck Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

Company Unit 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic ... ... ... ... ...           8.84 -1.44 0.493 -2.18 -1.76    
Bayer Czech Republic ... ... ...               -158 -257 21.4 12.8 19.2    
GlaxoSmithKline Czech Republic ... ... ...               -34.4 52.8 -2.39 -1.60 -21.5    
Merck Czech Republic ... ...                 147 -11.7 -7.57 9.06 13.5    
Novartis Czech Republic                     8.43 6.24 17.6 39.1 8.21    
Pfizer Czech Republic ... ...                 -17.5 -49.8 49.5 -8.06 -33.8    
Roche Czech Republic ... ... ...               -3.47 4.38 2.78 12.6 157   ...
Sanofi-Aventis Czech Republic ... ... ... ...             2.80 10.9 2.48 -7.42 27.8    
Servier Czech Republic ... ... ... ... ... ... ... ... ... ... ... ... -12.0 17.6 3.26    
Walmark ... ... ...               -8.72 12.5 -10.8 20.0 -69.9